Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: Results from a National Depression Cohort study in Korea (the CRESCEND study)
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 203, 190-198
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Sex differences in human adipose tissues – the biology of pear shapeBiology of Sex Differences, 2012
- Asian Americans have greater prevalence of metabolic syndrome despite lower body mass indexInternational Journal of Obesity, 2010
- Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcomeBipolar Disorders, 2010
- Can body mass index help predict outcome in patients with bipolar disorder?Bipolar Disorders, 2009
- Treatment-Resistant Depression and Mortality After Acute Coronary SyndromeAmerican Journal of Psychiatry, 2009
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesThe Lancet, 2009
- Sex differences in response to citalopram: A STAR∗D reportJournal of Psychiatric Research, 2009
- Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in ratsBehavioural Pharmacology, 2008
- Obesity and Systemic Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brainLife Sciences, 1997